NO20074897L - Radioaktive halogenmerkede fenyloksyanilinderivater - Google Patents

Radioaktive halogenmerkede fenyloksyanilinderivater

Info

Publication number
NO20074897L
NO20074897L NO20074897A NO20074897A NO20074897L NO 20074897 L NO20074897 L NO 20074897L NO 20074897 A NO20074897 A NO 20074897A NO 20074897 A NO20074897 A NO 20074897A NO 20074897 L NO20074897 L NO 20074897L
Authority
NO
Norway
Prior art keywords
radioactive halogen
pbr
labeled
alkoxy group
compound useful
Prior art date
Application number
NO20074897A
Other languages
English (en)
Inventor
Atsuro Nakazato
Kazutoshi Suzuki
Tetsuya Suhara
Halldin Christar
Ming-Rong Zhang
Original Assignee
Nat Inst Radiolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Radiolog filed Critical Nat Inst Radiolog
Publication of NO20074897L publication Critical patent/NO20074897L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Et radioaktivt halogenmerket fenyloksyanilinderivat representert ved den følgende formel: hvor R1 representerer en gruppe slik som en alkylgruppe; Xl, X2, X3 og X4 representerer hver et hydrogenatom, en alkylgruppe, en alkoksygruppe, en alkoksygruppe som bærer 11C introdusert deri eller et radioaktivt halogenatom, tilveiebrakt at minst en av Xl, X2, X3 og X4 representerer en alkoksygruppe som bærer 11C introdusert deri eller et radioaktivt halogenatom; som er en forbindelse nyttig som en PBR-ligand som har en høy affinitet og en høy selektivitet I in vitro måling av PBR er en PBR-ligand som har en høy affinitet og en høy selektivitet merket med en radioaktiv halogen nukleær art for a muliggjøre målingen av PBR in vivo med anvendelsen av midler ikke bare inkluderende PET, men også SPECT. En forbindelse som er nyttig i tidlig diagnostikk, forebygging og behandling av sykdommer slik som Alzheimers type demens kan på denne måten bli oppnådd.
NO20074897A 2005-02-28 2007-09-26 Radioaktive halogenmerkede fenyloksyanilinderivater NO20074897L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005052527 2005-02-28
PCT/JP2005/024075 WO2006092902A1 (ja) 2005-02-28 2005-12-28 放射性ハロゲン標識フェニルオキシアニリン誘導体

Publications (1)

Publication Number Publication Date
NO20074897L true NO20074897L (no) 2007-11-21

Family

ID=36940944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074897A NO20074897L (no) 2005-02-28 2007-09-26 Radioaktive halogenmerkede fenyloksyanilinderivater

Country Status (15)

Country Link
US (1) US20090234162A1 (no)
EP (1) EP1854781A1 (no)
JP (1) JPWO2006092902A1 (no)
KR (1) KR20070108883A (no)
CN (1) CN101133017A (no)
AU (1) AU2005328464B2 (no)
BR (1) BRPI0520092A2 (no)
CA (1) CA2599321A1 (no)
IL (1) IL185333A0 (no)
MX (1) MX2007010343A (no)
NO (1) NO20074897L (no)
RU (1) RU2425824C2 (no)
UA (1) UA93870C2 (no)
WO (1) WO2006092902A1 (no)
ZA (1) ZA200707226B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101563305A (zh) * 2006-12-21 2009-10-21 哈默史密斯网上成像有限公司 放射性标记方法
CA2680762A1 (en) * 2007-03-12 2008-09-25 National Institute Of Radiological Sciences Pet visualization of amyloid-associated neuroinflammation in the brain
EP1997515A1 (en) * 2007-05-30 2008-12-03 Bayer Schering Pharma Aktiengesellschaft Use of radiolabelled phenyloxyaniline derivatives for imaging diseases associated with peripheral benzodiazepin receptor's activation
JP5441060B2 (ja) * 2007-10-31 2014-03-12 独立行政法人理化学研究所 創薬のためのpetスクリーニング用分子プローブを製造するためのキット
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
GB0904715D0 (en) 2009-03-19 2009-05-06 Ge Healthcare Ltd Aryloxyanilide derivataives
GB0921967D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel Aryloxyanilide Derivatives
JP5422782B1 (ja) * 2012-12-21 2014-02-19 独立行政法人放射線医学総合研究所 脳内に蓄積したタウタンパク質をイメージングするための新規化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122361A (en) * 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
JP4302207B2 (ja) * 1997-08-04 2009-07-22 大正製薬株式会社 アリールオキシアニリン誘導体
DE69809063T2 (de) * 1997-08-04 2003-06-12 Nihon Nohyaku Co., Ltd. Aryloxyanilin-derivate
AU4975600A (en) * 1999-04-26 2000-11-10 Emory University 4-fluoroalkyl-3-halophenyl nortropanes
US6843979B2 (en) * 1999-04-26 2005-01-18 Emory University 4-haloethenylphenyl tropane:serotonin transporter imaging agents
RU2300516C2 (ru) * 1999-11-05 2007-06-10 Эмисфере Текнолоджиз, Инк. Соединения феноксикарбоновой кислоты и композиции для доставки активных веществ
US6870069B2 (en) * 2003-01-10 2005-03-22 National Institute Of Radiological Sciences Phenyloxyaniline derivatives

Also Published As

Publication number Publication date
EP1854781A1 (en) 2007-11-14
CA2599321A1 (en) 2006-09-08
UA93870C2 (ru) 2011-03-25
RU2007135882A (ru) 2009-04-10
BRPI0520092A2 (pt) 2009-08-18
AU2005328464B2 (en) 2011-02-24
AU2005328464A1 (en) 2006-09-08
KR20070108883A (ko) 2007-11-13
ZA200707226B (en) 2009-09-30
JPWO2006092902A1 (ja) 2008-08-07
WO2006092902A1 (ja) 2006-09-08
CN101133017A (zh) 2008-02-27
MX2007010343A (es) 2008-04-16
RU2425824C2 (ru) 2011-08-10
US20090234162A1 (en) 2009-09-17
IL185333A0 (en) 2008-02-09

Similar Documents

Publication Publication Date Title
NO20091428L (no) Forbindelser og metoder for 18F-merkede midler
Maeda et al. In vivo positron emission tomographic imaging of glial responses to amyloid-β and tau pathologies in mouse models of Alzheimer's disease and related disorders
MA50918B1 (fr) Nouveaux composés de chélate de gadolinium pour une utilisation dans l'imagerie par résonance magnétique
Ono et al. Recent advances in molecular imaging probes for β-amyloid plaques
TN2011000571A1 (fr) Anticorps humanises specifiques de la forme protofibrillaire du peptide beta amyloide
NO20080590L (no) Humane, monoklonale antistoffer mot programmert dodsligand (PD-L1)
BR112015029318A2 (pt) marcadores específicos de caminhos para diagnóstico da síndrome do intestino irritável
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
WO2013022953A3 (en) Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
NO20060230L (no) Nye aminobenzofenonforbindelser
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
MA32882B1 (fr) Nouveaux pyrazole-4-n-alkoxycarboxamides en tant que microbiocides
BRPI0617151B8 (pt) composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico
NO20075671L (no) Neurodegenerative markorer for psykiatriske tilstander
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
MA31690B1 (fr) Nouveaux fongicides
MA35808B1 (fr) Benzoxazépinones fusionnés en tant que modulateurs des canaux ioniques
WO2009054497A1 (ja) 新規アミロイド親和性化合物
EA200901347A1 (ru) F-меченые фолаты
EA200800879A1 (ru) Агонисты ppar гамма для улучшения когнитивной функции у apoe4 отрицательных пациентов
EA201291040A1 (ru) Использование скорости увеличения желудочков при лечении болезни альцгеймера внутривенным иммуноглобулином
MA34291B1 (fr) Compositions et méthodes de diagnostic et de traitement d'une tumeur
UA93870C2 (ru) Меченные радиоактивным галогеном производные фенилоксианилина
MX2009003617A (es) Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet).

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application